Video Latest - ecancer

Emerging treatments for relapsed/refractory Hodgkin’s lymphoma in China

Dr Qingqing Cai - Sun Yat-Sen University, Guangzhou, China

$Emerging treatments for relapsed/refractory Hodgkin’s lymphoma in China ( Dr Qingqing Cai - Sun Yat-Sen University, Guangzhou, China )$

29 Jan 2021

Breast cancer surveillance

Dr Supriya Kulkarni - University of Toronto, Toronto, Canada

28 Jan 2021

Imaging of lobular carcinoma

Dr Supriya Kulkarni - University of Toronto, Toronto, Canada

28 Jan 2021

Pre-operative staging with breast MRI

Dr Supriya Kulkarni - University of Toronto, Toronto, Canada

28 Jan 2021

BRCA mutation in metastatic TNBC patients

Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon

28 Jan 2021

Is chemotherapy only a treatment of last resort in luminal breast cancers?

Prof David Cameron - University of Edinburgh, Edinburgh, UK

27 Jan 2021

The role of immune checkpoint inhibitors in NSCLC

Dr Maurice Pérol, Centre Léon Bérard, Lyon, France

27 Jan 2021

Challenges in oncology management during the COVID-19 era

Prof Matti Aapro - Genolier Cancer Centre, Genolier, Switzerland

27 Jan 2021

OncoAlert and ecancer weekly roundup for January 18 - 24, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

25 Jan 2021

OncoAlert and ecancer weekly roundup for January 11 - 17, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

21 Jan 2021

Updates on criteria for patient selection and surgical management in advanced ovarian cancer

Prof Pedro Ramirez - MD Anderson Cancer Center, Houston, USA

20 Jan 2021

Ferroptosis regulator as a novel therapeutic target for STK11/KEAP1 co-mutant lung adenocarcinoma

Dr Triparna Sen - Memorial Sloan Kettering Cancer Center, New York, USA

20 Jan 2021

Video